A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer
Public ClinicalTrials.gov record NCT06315491. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase 2 Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer
Study identification
- NCT ID
- NCT06315491
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Cybrexa Therapeutics
- Industry
- Enrollment
- 40 participants
Conditions and interventions
Interventions
- CBX-12 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 24, 2024
- Primary completion
- Sep 30, 2025
- Completion
- Sep 30, 2025
- Last update posted
- Oct 5, 2025
2024 – 2025
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Honor Health | Scottsdale | Arizona | 85260 | Withdrawn |
| Arizona Oncology Associates | Tucson | Arizona | 85711 | Active, not recruiting |
| Usc Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | Active, not recruiting |
| Yale University School of Medicine | New Haven | Connecticut | 06510 | Active, not recruiting |
| D&H Cancer Research Center | Margate | Florida | 33063 | Active, not recruiting |
| South Florida Gynecology | Tampa | Florida | 33606 | Active, not recruiting |
| Northwest Cancer Centers | Dyer | Indiana | 46311 | Withdrawn |
| Norton Cancer Institute | Louisville | Kentucky | 40202 | Active, not recruiting |
| Women's Cancer Care | Covington | Louisiana | 70433 | Active, not recruiting |
| Pci Nyu Langone Health | New York | New York | 10016 | Active, not recruiting |
| Albert Einstein College of Medicine Montefiore Medical | New York | New York | 10021 | Active, not recruiting |
| University Hospitals Seidman Cancer Center | Cleveland | Ohio | 44106 | Active, not recruiting |
| Oncology Associates of Oregon | Eugene | Oregon | 97401 | Active, not recruiting |
| Allegheny Singer Research Institute D/B/A Ahn Research Institution | Pittsburgh | Pennsylvania | 15212 | Recruiting |
| Mary Crowley Cancer Research | Dallas | Texas | 75251 | Recruiting |
| Texas Oncology- Gulf Coast | The Woodlands | Texas | 77380 | Active, not recruiting |
| Multicare Institute For Research & Innovation | Tacoma | Washington | 98405 | Active, not recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06315491, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 5, 2025 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06315491 live on ClinicalTrials.gov.